rawfin.tv
Lexeo Therapeutics COO Reports Stock Award and Tax Sale
MarketsstocksAI Generated

Lexeo Therapeutics COO Reports Stock Award and Tax Sale

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Lexeo Therapeutics' Chief Operating Officer, Jose Manuel Otero, received a stock grant of 12,060 shares. A small portion of these shares was subsequently sold for tax-related purposes.

Lexeo TherapeuticsInsider TradingStock AwardBiotechnology

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks